Surgical Science Sweden AB (SUS) - Total Assets
Based on the latest financial reports, Surgical Science Sweden AB (SUS) holds total assets worth Skr4.97 Billion SEK (≈ $534.95 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Surgical Science Sweden AB - Total Assets Trend (2014–2025)
This chart illustrates how Surgical Science Sweden AB's total assets have evolved over time, based on quarterly financial data. Also see Surgical Science Sweden AB stock valuation for the company's overall valuation and market capitalisation.
Surgical Science Sweden AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Surgical Science Sweden AB's total assets of Skr4.97 Billion consist of 25.3% current assets and 74.8% non-current assets. Review Surgical Science Sweden AB total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 13.1% |
| Accounts Receivable | Skr289.23 Million | 6.2% |
| Inventory | Skr205.97 Million | 4.4% |
| Property, Plant & Equipment | Skr106.35 Million | 2.3% |
| Intangible Assets | Skr322.65 Million | 6.9% |
| Goodwill | Skr3.08 Billion | 65.6% |
Asset Composition Trend (2014–2025)
This chart illustrates how Surgical Science Sweden AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Surgical Science Sweden AB (SUS) share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Surgical Science Sweden AB's current assets represent 25.3% of total assets in 2025, a decrease from 42.1% in 2014.
- Cash Position: Cash and equivalents constituted 13.1% of total assets in 2025, up from 0.3% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 71.0% of total assets, an increase from 54.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 65.6% of total assets.
Surgical Science Sweden AB Competitors by Total Assets
Key competitors of Surgical Science Sweden AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Heren Health Co Ltd
SHE:300550
|
China | CN¥1.41 Billion |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
Trivarx Ltd
AU:TRI
|
Australia | AU$16.53 Million |
|
Opyl Ltd
AU:OPL
|
Australia | AU$384.82K |
|
Oakridge International Ltd
AU:OAK
|
Australia | AU$2.12 Million |
|
Carespan Health Inc
V:CSPN
|
Canada | CA$116.81K |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
Surgical Science Sweden AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.24 | 4.09 | 2.45 |
| Quick Ratio | 3.45 | 3.32 | 1.90 |
| Cash Ratio | 0.00 | 0.00 | 1.40 |
| Working Capital | Skr963.07 Million | Skr830.74 Million | Skr322.08 Million |
Surgical Science Sweden AB - Advanced Valuation Insights
This section examines the relationship between Surgical Science Sweden AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.58 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | -14.4% |
| Total Assets | Skr4.69 Billion |
| Market Capitalization | $271.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values Surgical Science Sweden AB's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Surgical Science Sweden AB's assets decreased by 14.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Surgical Science Sweden AB (2014–2025)
The table below shows the annual total assets of Surgical Science Sweden AB from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr4.69 Billion ≈ $504.87 Million |
-14.39% |
| 2024-12-31 | Skr5.48 Billion ≈ $589.70 Million |
+16.52% |
| 2023-12-31 | Skr4.70 Billion ≈ $506.08 Million |
+1.14% |
| 2022-12-31 | Skr4.65 Billion ≈ $500.37 Million |
+16.88% |
| 2021-12-31 | Skr3.98 Billion ≈ $428.11 Million |
+742.34% |
| 2020-12-31 | Skr472.27 Million ≈ $50.82 Million |
+3.52% |
| 2019-12-31 | Skr456.21 Million ≈ $49.10 Million |
+357.77% |
| 2018-12-31 | Skr99.66 Million ≈ $10.72 Million |
+0.75% |
| 2017-12-31 | Skr98.92 Million ≈ $10.65 Million |
+55.29% |
| 2016-12-31 | Skr63.70 Million ≈ $6.86 Million |
+16.45% |
| 2015-12-31 | Skr54.70 Million ≈ $5.89 Million |
+10.88% |
| 2014-12-31 | Skr49.33 Million ≈ $5.31 Million |
-- |
About Surgical Science Sweden AB
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquis… Read more